Vagelos P Roy

Insider Reports History

Entity
Company
Signature
/s/**P. Roy Vagelos
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vagelos P Roy:

Stock Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. Director Common Stock 313K $297M $951.26 Apr 3, 2023 Direct
REGENERON PHARMACEUTICALS, INC. Director Common Stock 125K $119M $951.26 Apr 3, 2023 by CLAT
REGENERON PHARMACEUTICALS, INC. Director Common Stock 23.5K $22.3M $951.26 Apr 3, 2023 by Spouse as Trustee
REGENERON PHARMACEUTICALS, INC. Director Common Stock 3.61K $3.43M $951.26 Apr 3, 2023 by trust for grandch
REGENERON PHARMACEUTICALS, INC. Director Common Stock 1.96K $1.87M $951.26 Apr 3, 2023 By 401(k) Plan

Insider Reports Filed by Vagelos P Roy

Symbol Company Period Transactions Value $ Form Type Date Filed Role
REGN REGENERON PHARMACEUTICALS, INC. Apr 3, 2023 1 $0 4 Apr 5, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Mar 23, 2023 1 $0 4 Mar 27, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Feb 22, 2023 4 -$10.3M 4 Feb 24, 2023 Director
REGN REGENERON PHARMACEUTICALS, INC. Dec 20, 2022 2 -$103K 4 Dec 21, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Dec 16, 2022 2 $0 4 Dec 20, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Dec 9, 2022 5 -$42.9K 4 Dec 13, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Mar 30, 2022 2 -$20M 4 Apr 1, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Mar 14, 2022 4 -$18.1M 4 Mar 15, 2022 Director
REGN REGENERON PHARMACEUTICALS, INC. Dec 16, 2021 2 -$80K 4 Dec 20, 2021 Director
REGN REGENERON PHARMACEUTICALS, INC. Dec 8, 2021 3 $0 4 Dec 10, 2021 Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 25, 2021 3 -$19.5M 4 Aug 27, 2021 Director
REGN REGENERON PHARMACEUTICALS, INC. Aug 18, 2021 6 -$6.53M 4 Aug 19, 2021 Director